Fcγ receptor IIa polymorphism in patients with brucellosis

Japanese Journal of Infectious Diseases

Volumn 60, Issue 4, 2007, Pages 196-197

  Hashemi, Sayyed Hamid ^a   Hajilooi, Mehrdad ^a   Mamani, Mojgan ^a   Jamal Omidi, Shirin ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIA; UNCLASSIFIED DRUG;

ARTICLE; BRUCELLOSIS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INFECTION RISK; IRAN; MALE; NONHUMAN; POLYMERASE CHAIN REACTION;

ALLELES; ANIMALS; ANTIGENS, CD; BRUCELLA; BRUCELLOSIS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 34548398615     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. van de Winkel, J.G. and Capel, P.J. (1993): Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today, 14, 215-221.
2. Parren, P.W., Warmerdam, P.A., Boeije, L.C., et al. (1992): Characterization of IgG FcR-mediated proliferation of human T cells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3. J. Immunol., 148, 695-701.
3. Karassa, F.B., Trikalinos, T.A. and Ioannidis, J.P. (2004): The role of FCgammaRIIa and IIIa polymorphisms in autoimmune diseases. Biomed. Pharmacother., 58, 286-291.
4. Yee, A.M., Phan, H.M., Zuniga, R., et al. (2002): Association between FC gamma RIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin. Infect Dis., 30, 25-28.
5. Domingo, P., Muniz-Diaz, E., Baraldes, M.A., et al. (2002): Association between FC gamma RIIa polymorphisms and the risk and prognosis of meningococcal disease. Am. J. Med., 112, 19-25.
6. Skamene, E., Schurr, E. and Gres, P. (1998): Infection gmomics Nramp 1 as a major determinant of natural resistance to intracellular infection. Annu. Rev. Med., 49, 275-287.
7. Adams, L.G. and Templeton, J.W. (1998): Genetic resistance to bacterial diseases in animals. Rev. Sci. Tech. (Off. Int. Epizoot.), 17, 200-219.
8. Miller, S.A., Dyakes, D.D. and Polesky, H.F. (1988): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215-1218.
9. Flesch, B.K., Bauer, F. and Neppert, J. (1998): Rapid typing of the human FC gamma RIIa polymorphism by polymerase chain reaction amplification with allele-specific primers. Transfusion, 38, 174-176.
10. Rezazadeh, M., Hajilooi, M., Rafiei, A., et al. (2006): TLR4 polymorphism in Iranian patients with brucellosis. J. Infect., 53, 206-210.
11. Rafiei, A., Hajilooi, M., Shakib, R.J., et al. (2006): Association between the Phe206Leu polymorphism of L-selectin and brucellosis. J. Med. Microbiol., 55, 511-516.
12. Rezazadeh, M., Hajilooi, M., Haidari, M., et al. (2006): Association of susceptibility to brucellosis and interleukin-4 promoter polymorphism. Scand. J. Infect. Dis., 38, 1045-1049.
13. Hajilooi, M., Rafiei, A., Rezazadeh, M., et al. (2006): Association of interleukin-1 receptor antagonist gene polymorphism and susceptibility to human brucellosis. Tissue Antigens, 68, 331-334.
14. Rafiei, A., Hajilooi, M., Shakib, R.J., et al. (2007): Transforming growth factor-β1 polymorphisms in patients with brucellosis: an association between codon 10 and 25 polymorphisms and brucellosis. Clin. Microbiol. Infect., 13, 97-100.
15. Haidari, M., Rezazadeh, M., Hajilooi, M., et al. (2006): Polymorphism in the promoter region of the CD14 gene and susceptibility to brucellosis. Immunol. Invest., 35, 239-245.
16. Cooke, G.S., Aucan, C., Walley, A.J., et al. (2003): Association of FCγRIIa (CD32) polymorphism with severe malaria in West Africa. Am. J. Trop. Med. Hyg., 69, 565-568.